
Loading, please wait...

Loading, please wait...

Clinicians often search for reliable biomarkers to predict patient outcomes after invasive vascular procedures. Specifically, recent research suggests that the ABO blood group stroke risk plays a pivotal role in cerebrovascular health. Therefore, a retrospective study involving 316 patients analyzed the association between blood type and complications following carotid angiography and stenting (CAS). Moreover, the findings indicate that patients with non-O blood groups (A, B, or AB) face a significantly higher risk of serious neurological events.
Specifically, the study compared 106 patients with blood group O against 210 patients with non-O blood groups. Additionally, results showed that stroke occurred in 13.8% of patients with non-O blood groups, whereas only 1.9% of those with blood group O were affected. Furthermore, transient ischemic attacks (TIA) were also significantly more frequent in the non-O group. Consequently, this disparity suggests that ABO antigens may serve as natural thrombotic markers. Thus, medical teams should consider adapting their risk assessment strategies based on a patient's blood type.
Why does the ABO blood group stroke risk vary so significantly between individuals? Scientists believe that higher levels of von Willebrand factor (VWF) and Factor VIII in non-O individuals contribute to this prothrombotic state. Specifically, these proteins facilitate platelet adhesion and thrombus formation, which can lead to procedural complications. However, while these results are compelling, practitioners must integrate them with other clinical parameters. Moreover, identifying high-risk patients early allows for better perioperative management and individualized care.
Yes, the study indicates that patients with blood group O have a significantly lower incidence of stroke and TIA following carotid artery stenting compared to those with non-O blood types.
Individuals with blood groups A, B, and AB typically have higher circulating levels of von Willebrand factor and Factor VIII. These factors increase the likelihood of blood clot formation during and after vascular procedures.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Evsen A et al. ABO blood group and cerebrovascular complications after carotid angiography and stenting: a natural thrombotic marker? J Clin Neurosci. 2026 Jun 07. doi: undefined. PMID: 42251813.
Sharma P et al. Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease - PubMed. J Stroke Cerebrovasc Dis. 2023. doi: 10.1016/j.jstrokecerebrovasdis.2023.107215.
Liumbruno GM et al. ABO blood group and thromboembolic diseases. IntechOpen. 2022. doi: 10.5772/intechopen.102123.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study suggests non-O blood groups significantly increase the risk of stroke following carotid artery stenting compared to the O blood group....
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today